While Congress fails to stave off cuts to HIV care, community leaders in Mississippi and beyond race to limit the damage.

States and cities were prepared to submit the information they collected to the CDC in April so the agency's statisticians ...

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be HIV-negative to get it.

The Centers for Disease Control and Prevention is the latest agency in the Health and Human Services Department to rehire ...

A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...

The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported ...

A revolutionary new preventative medicine that protects against the HIV virus has just been approved by the U.S. Food and ...

The US Department of Health and Human Services is reinstating more than 450 employees at the US Centers for Disease Control ...

The launch of the injection faces potential threats, including the Trump administration's proposed cuts to federal funding ...

In two recent studies, this new shot reportedly nearly eliminated new infections in people at substantial risk of HIV.

A new analysis of all the cases reported between July last year and February 2025 also indicates most patients (62 per cent) reported genital wounds, which means the disease was sexually ...